We are live on ! Find out more
AC

Amici Capital Portfolio holdings

AUM $257M
1-Year Est. Return 4.88%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+4.88%
3 Year Est. Return
+28.64%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$126M
Cap. Flow
-$109M
Cap. Flow %
-42.46%
Top 10 Hldgs %
54.36%
Holding
106
New
17
Increased
10
Reduced
24
Closed
48

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.47%
2 Healthcare 23.9%
3 Financials 12.96%
4 Communication Services 9.84%
5 Materials 7.48%

No holdings matched the selected filter criteria.

Similar funds

Amici Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Amici Capital held 106 positions worth $257M, down 33% from $383M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Amici Capital withdrew a net $109M in Q4 2016, closing 48 positions and reducing 24 holdings. Its most notable exit was Teva Pharmaceutical Industries Limited, an estimated $5.45M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Amici Capital opened a new position in First Connecticut Bancorp, Inc worth $32K.

  • Amici Capital's largest Q4 2016 buy was First Connecticut Bancorp, Inc: 250,000 shares worth $32K.
  • Amici Capital added most to Hecla Mining in Q4 2016, an estimated $2.74M increase.
  • Amici Capital's biggest Q4 2016 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.33M.
  • Amici Capital fully exited Teva Pharmaceutical Industries Limited in Q4 2016, selling an estimated $5.45M.
  • Amici Capital's ten largest holdings make up 54% of its $257M portfolio in Q4 2016.
  • Amici Capital opened 17 new positions and closed 48 in Q4 2016.
  • Amici Capital's portfolio value fell 33% quarter-over-quarter to $257M.

Based on Amici Capital's 13F filing for Q4 2016, filed 14 Feb 2017.